Advertisement

The relationship between the prognosis of children with acute arterial stroke and polymorphisms of CDKN2B, HDAC9, NINJ2, NAA25 genes

  • Adil Bozpolat
  • Ekrem UnalEmail author
  • Tugba Topaloglu
  • Serpil Taheri
  • Ayse Kacar Bayram
  • Alper Ozcan
  • Musa Karakukcu
  • Mehmet Akif Ozdemir
  • Huseyin PerEmail author
Article
  • 30 Downloads

Abstract

Ischemic stroke is a significant health condition, whose frequency in childhood is increasing day by day. Although many factors are effective in development of the stroke, it has been showed that individuals having risk factors have a genetic predisposition. The aim of the study is to determine whether distinct genetic mutations are risk factors for children with history of ischemic stroke. Our sample data is taken from 58 patients (29 male and 29 female) who applied our hospital between 2012 and 2016 with diagnosis of acute or chronic arterial stroke and from 70 healthy children (32 male and 38 female) with similar particularities in the sense of age and sex, who have not any chronical disease. Blood samples are taken from each child participated in the study to conduct genetic analysis. It has been examined whether a mutation exists in gene locations of CDKN2B-AS1 (Rs2383206), HDAC9 (Rs11984041), NINJ2 (Rs12425791), NAA25 (Rs17696736). Moreover, whether there are significant difference between patient and control group has been investigated. In the genetic analysis of patients and control groups, no significant difference has been found for any of the genes. Mutations in gene locations of CDKN2B-AS1 (Rs2383206), HDAC9 (Rs11984041), NINJ2 (Rs12425791), NAA25 (Rs17696736) are not risk factors for ischemic stroke in childhood. However this study showed us, the patients who inherit CDKN2B-AS1 and HDCA9 gene mutations had poor prognosis. However, this study should be replicated for a wider sample of patient population.

Keywords

Children Ischemic stroke CDKN2B HDAC9 NINJ2 NAA25 

References

  1. 1.
    Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T (1980) Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ 58(1):113–130Google Scholar
  2. 2.
    Lynch JK (2004) Cerebrovascular disorders in children. Curr Neurol Neurosci Rep 4(2):129–138CrossRefGoogle Scholar
  3. 3.
    Unal E, Yazar A, Koksal Y, Caliskan U, Paksoy Y, Kalkan E (2008) Cerebral venous sinus thrombosis in an adolescent with Ewing sarcoma. Childs Nerv Syst 24(9):983–986.  https://doi.org/10.1007/s00381-008-0646-0 CrossRefGoogle Scholar
  4. 4.
    Brankovic-Sreckovic V, Milic-Rasic V, Jovic N, Milic N, Todorovic S (2004) The recurrence risk of ischemic stroke in childhood. Med Princ Pract 13(3):153–158.  https://doi.org/10.1159/000076955 CrossRefGoogle Scholar
  5. 5.
    Huang HD, Yang CM, Shu HF, Kuang YQ, Yang T, He WQ, Zhao K, Xia X, Cheng JM, Ma Y, Gu JW (2015) Genetic predisposition of stroke: understanding the evolving landscape through meta-analysis. Int J Clin Exp Med 8(1):1315–1323Google Scholar
  6. 6.
    Cheng Y-C, Cole JW, Kittner SJ, Mitchell BD (2014) Genetics of ischemic stroke in young adults. Circulation 7(3):383–392Google Scholar
  7. 7.
    Lindgren A (2014) Stroke genetics: a review and update. J Stroke 16(3):114CrossRefGoogle Scholar
  8. 8.
    Samani NJ, Schunkert H (2008) Chromosome 9p21 and cardiovascular disease: the story unfolds. Circulation 1(2):81–84.  https://doi.org/10.1161/CIRCGENETICS.108.832527 Google Scholar
  9. 9.
    McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, Cox DR, Hinds DA, Pennacchio LA, Tybjaerg-Hansen A, Folsom AR (2007) A common allele on chromosome 9 associated with coronary heart disease. Science 316(5830):1488–1491CrossRefGoogle Scholar
  10. 10.
    Do R, Xie C, Zhang X, Mannisto S, Harald K, Islam S, Bailey SD, Rangarajan S, McQueen MJ, Diaz R, Lisheng L, Wang X, Silander K, Peltonen L, Yusuf S, Salomaa V, Engert JC, Anand SS (2011) The effect of chromosome 9p21 variants on cardiovascular disease may be modified by dietary intake: evidence from a case/control and a prospective study. PLoS Med 8(10):e1001106.  https://doi.org/10.1371/journal.pmed.1001106 CrossRefGoogle Scholar
  11. 11.
    Markus HS, Mäkelä K-M, Bevan S, Raitoharju E, Oksala N, Bis JC, O’Donnell C, Hainsworth A, Lehtimäki T (2013) Evidence HDAC9 genetic variant associated with ischemic stroke increases risk via promoting carotid atherosclerosis. Stroke 44(5):1220–1225CrossRefGoogle Scholar
  12. 12.
    Markus HS (2013) WellcomeTrust genome-wide association study of ischemic stroke. Stroke 44(6 Suppl 1):S20–S22.  https://doi.org/10.1161/STROKEAHA.112.680652 CrossRefGoogle Scholar
  13. 13.
    Kim DE, Noh SM, Jeong SW, Cha MH (2012) NINJ2 SNP may affect the onset age of first-ever ischemic stroke without increasing silent cerebrovascular lesions. BMC Res Notes 5:155.  https://doi.org/10.1186/1756-0500-5-155 CrossRefGoogle Scholar
  14. 14.
    Araki T, Milbrandt J (2000) Ninjurin2, a novel homophilic adhesion molecule, is expressed in mature sensory and enteric neurons and promotes neurite outgrowth. J Neurosci 20(1):187–195CrossRefGoogle Scholar
  15. 15.
    Jiang F, Yan H, Wu C, Song C, Zhao B, Li Y, Dong J, Zheng GY, Jin LJ, Li XQ, Li WY, Cai J, Yang XC, Tian XL (2016) A novel block at chromosome 12q24.1 is associated with coronary artery disease in Han Chinese populations. Pharmacogenet Genomics 26(11):497–504.  https://doi.org/10.1097/FPC.0000000000000242 CrossRefGoogle Scholar
  16. 16.
    Goksuluk D, Korkmaz S, Zararsiz G, Karaagaoglu AE (2016) easyROC: an interactive web-tool for ROC curve analysis using R language environment. R J 8:213–230Google Scholar
  17. 17.
    Korkmaz S, Goksuluk D, Zararsiz G (2014) MVN: an R package for assessing multivariate normality. R J 6(2):151–162Google Scholar
  18. 18.
    Patra C, Sarkar S, Guha D, Dasgupta MK (2015) Clinico-etiological profile of childhood stroke in a Tertiary Care Hospital in Eastern India. J Neurosci Rural Pract 6(4):515CrossRefGoogle Scholar
  19. 19.
    Pergami P, Thayapararajah SW, Seemaladinne N (2015) West Virginia University pediatric stroke registry: clinical description and risk factors identification in patients from a rural area. Clin Pediatr 54(1):40–46CrossRefGoogle Scholar
  20. 20.
    Mackay MT, Wiznitzer M, Benedict SL, Lee KJ, Deveber GA, Ganesan V (2011) Arterial ischemic stroke risk factors: the International Pediatric Stroke Study. Ann Neurol 69(1):130–140CrossRefGoogle Scholar
  21. 21.
    Per H, Unal E, Poyrazoglu HG, Ozdemir MA, Donmez H, Gumus H, Uzum K, Canpolat M, Akyildiz BN, Coskun A (2014) Childhood stroke: results of 130 children from a reference center in Central Anatolia, Turkey. Pediatr Neurol 50(6):595–600CrossRefGoogle Scholar
  22. 22.
    Masri A, Al-Ammouri I (2016) Clinical presentation, etiology, and outcome of stroke in children: a hospital-based study. Brain Dev 38(2):204–208.  https://doi.org/10.1016/j.braindev.2015.08.007 CrossRefGoogle Scholar
  23. 23.
    Muwakkit SA, Majdalani M, Hourani R, Mahfouz RA, Otrock ZK, Bilalian C, Chan AK, Abboud M, Mikati MA (2011) Inherited thrombophilia in childhood arterial stroke: data from Lebanon. Pediatr Neurol 45(3):155–158.  https://doi.org/10.1016/j.pediatrneurol.2011.03.002 CrossRefGoogle Scholar
  24. 24.
    Shatla HM, Tomoum HY, Elsayed SM, Aly RH, Shatla RH, Ismail MA, El-Ghany NA, Fakhry AI, Abd Allah NA, Yonca E, Nejat AM (2012) Inherited thrombophilia in pediatric ischemic stroke: an Egyptian study. Pediatr Neurol 47(2):114–118.  https://doi.org/10.1016/j.pediatrneurol.2012.05.008 CrossRefGoogle Scholar
  25. 25.
    Morita DC, Donaldson A, Butterfield RJ, Benedict SL, Bale JF Jr (2009) Methylenetetrahydrofolate reductase gene polymorphism and childhood stroke. Pediatr Neurol 41(4):247–249.  https://doi.org/10.1016/j.pediatrneurol.2009.04.017 CrossRefGoogle Scholar
  26. 26.
    Incecik F, Ozlem Herguner M, Altunbasak S (2010) Risk factors and treatment outcomes for children with arterial ischemic stroke. J Clin Neurosci 17(8):1000–1002.  https://doi.org/10.1016/j.jocn.2010.01.004 CrossRefGoogle Scholar
  27. 27.
    Barreirinho S, Ferro A, Santos M, Costa E, Pinto-Basto J, Sousa A, Sequeiros J, Maciel P, Barbot C, Barbot J (2003) Inherited and acquired risk factors and their combined effects in pediatric stroke. Pediatr Neurol 28(2):134–138CrossRefGoogle Scholar
  28. 28.
    Zee RY, Ridker PM (2007) Two common gene variants on chromosome 9 and risk of atherothrombosis. Stroke 38(10):e111.  https://doi.org/10.1161/STROKEAHA.107.497669 CrossRefGoogle Scholar
  29. 29.
    Wahlstrand B, Orho-Melander M, Delling L, Kjeldsen S, Narkiewicz K, Almgren P, Hedner T, Melander O (2009) The myocardial infarction associated CDKN2A/CDKN2B locus on chromosome 9p21 is associated with stroke independently of coronary events in patients with hypertension. J Hypertens 27(4):769–773.  https://doi.org/10.1097/HJH.0b013e328326f7eb CrossRefGoogle Scholar
  30. 30.
    Anderson CD, Biffi A, Rost NS, Cortellini L, Furie KL, Rosand J (2010) Chromosome 9p21 in ischemic stroke: population structure and meta-analysis. Stroke 41(6):1123–1131.  https://doi.org/10.1161/STROKEAHA.110.580589 CrossRefGoogle Scholar
  31. 31.
    Hacke W, Grond-Ginsbach C (2012) Commentary on a GWAS: HDAC9 and the risk for ischaemic stroke. BMC Med.  https://doi.org/10.1186/1741-7015-10-70 Google Scholar
  32. 32.
    Malik R, Traylor M, Pulit SL, Bevan S, Hopewell JC, Holliday EG, Zhao W, Abrantes P, Amouyel P, Attia JR, Battey TW, Berger K, Boncoraglio GB, Chauhan G, Cheng YC, Chen WM, Clarke R, Cotlarciuc I, Debette S, Falcone GJ, Ferro JM, Gamble DM, Ilinca A, Kittner SJ, Kourkoulis CE, Lemmens R, Levi CR, Lichtner P, Lindgren A, Liu J, Meschia JF, Mitchell BD, Oliveira SA, Pera J, Reiner AP, Rothwell PM, Sharma P, Slowik A, Sudlow CL, Tatlisumak T, Thijs V, Vicente AM, Woo D, Seshadri S, Saleheen D, Rosand J, Markus HS, Worrall BB, Dichgans M, ISGC Analysis Group, METASTROKE Collaboration, Wellcome Trust Case Control Consortium 2, NINDS Stroke Genetics Network (2016) Low-frequency and common genetic variation in ischemic stroke: the METASTROKE collaboration. Neurology 86(13):1217–1226.  https://doi.org/10.1212/WNL.0000000000002528 CrossRefGoogle Scholar
  33. 33.
    Li BH, Zhang LL, Yin YW, Pi Y, Guo L, Yang QW, Gao CY, Fang CQ, Wang JZ, Li JC (2012) Association between 12p13 SNPs rs11833579/rs12425791 near NINJ2 gene and ischemic stroke in East Asian population: evidence from a meta-analysis. J Neurol Sci 316(1–2):116–121.  https://doi.org/10.1016/j.jns.2012.01.010 CrossRefGoogle Scholar
  34. 34.
    International Stroke Genetics C, Wellcome Trust Case-Control C (2010) Failure to validate association between 12p13 variants and ischemic stroke. N Engl J Med 362(16):1547–1550.  https://doi.org/10.1056/NEJMc0910050 CrossRefGoogle Scholar
  35. 35.
    Ganesan V, Hogan A, Shack N, Gordon A, Isaacs E, Kirkham FJ (2000) Outcome after ischaemic stroke in childhood. Dev Med Child Neurol 42(7):455–461CrossRefGoogle Scholar
  36. 36.
    Yilmaz E, Kacar AB, Bozpolat A, Zararsiz G, Gorkem BS, Karakukcu M, Patiroglu T, Gumus H, Ozdemir MA, Ozcan A (2017) The relationship between hematological parameters and prognosis of children with acute ischemic stroke. Child’s Nerv Syst 34:655–661CrossRefGoogle Scholar
  37. 37.
    Nasiri J, Ariyana A, Yaghini O, Ghazavi MR, Keikhah M, Salari M (2016) Neurological outcome after arterial ischemic stroke in children. Adv Biomed Res 5:107.  https://doi.org/10.4103/2277-9175.183668 CrossRefGoogle Scholar
  38. 38.
    Emam AT, Ali AM, Babikr MA (2009) Childhood stroke in Eastern Province, KSA: pattern, risk factors, diagnosis and outcome. Acta Paediatr 98(10):1613–1619.  https://doi.org/10.1111/j.1651-2227.2009.01421.x CrossRefGoogle Scholar
  39. 39.
    Soyuer F, Özarslan M, Soyuer A (2004) Ischemic stroke: impairment and disability. Erciyes Med J 26(1):19–24Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Division of Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of MedicineErciyes UniversityKayseriTurkey
  2. 2.Molecular Biology and Genetic Department, Genome and Stem Cell Center (GENKOK)Gevher Nesibe Genom and Stem Cell Institution, Erciyes UniversityKayseriTurkey
  3. 3.Department of Medical Genetics, Faculty of MedicineErciyes UniversityKayseriTurkey
  4. 4.Betul-Ziya Eren Genome and Stem Cell Center (GENKOK)Erciyes University Medical FacultyKayseriTurkey
  5. 5.Division of Pediatric Neurology, Department of Pediatrics, Faculty of MedicineErciyes UniversityKayseriTurkey

Personalised recommendations